Details for New Drug Application (NDA): 020519
✉ Email this page to a colleague
The generic ingredient in CICLOPIROX is ciclopirox. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.
Summary for 020519
Tradename: | CICLOPIROX |
Applicant: | Alvogen |
Ingredient: | ciclopirox |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TOPICAL | Strength | 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 21, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020519
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | ⤷ Subscribe | ⤷ Subscribe |
Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription